treatment limit small-cel lung cancer concurr etoposide/cisplatin radiotherapi intensif high-dos cyclophosphamid southwest oncolog group studi march may southwest oncolog group untreat patient limit small-cel lung cancer treatment program high-dos cyclophosphamid mg/kg late intensif treatment induct chemo-radiotherapi week consolid chemotherapi week intensif week median age year eighty-nin percent patient southwest oncolog group swog perform statu patient prescrib treatment treatment-rel death result intensif fifty-six patient avail respons analysi thirty-two patient complet remiss CR fifteen partial remiss PR median surviv patient month patient intensif aliv CR median surviv month sequenc treatment surviv advantag group whole toxic induct consolid treatment delay administr high-dos cyclophosphamid 